|Bid||228.91 x 900|
|Ask||229.80 x 1200|
|Day's Range||225.40 - 230.85|
|52 Week Range||119.60 - 240.51|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||46.28|
|Earnings Date||Jan 28, 2021 - Feb 01, 2021|
|Forward Dividend & Yield||0.72 (0.31%)|
|Ex-Dividend Date||Sep 25, 2020|
|1y Target Est||262.67|
The company's diagnostic tests and life sciences research tools are being extensively used in the fight against the pandemic.
Danaher (DHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
These large caps have improved their quarterly top and bottom lines significantly